SPRC
Scisparc Ltd
NASDAQ: SPRC · HEALTHCARE · BIOTECHNOLOGY
$5.08
+2.63% today
Updated 2026-09-11
Market cap
$122.06M
P/E ratio
0.05
P/S ratio
142.59x
EPS (TTM)
$98.07
Dividend yield
—
52W range
$3 – $80
Volume
0.2M
Scisparc Ltd (SPRC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$5.08
12-Month target
$21,464.34
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 0.05x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.